Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-23
1992-02-11
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514410, A61K 3140
Patent
active
050876228
ABSTRACT:
Method of decreasing the production of thyroid hormones in animals by parenteral administration of defined quantities of cobalt protoporphyrin or cobalt mesoporphyrin.
REFERENCES:
patent: 4393071 (1983-07-01), Fujii et al.
patent: 4656186 (1987-04-01), Bommer et al.
patent: 4693885 (1927-09-01), Bommer et al.
Galbraith, et al., Neuroendocrinology 1989, pp. 641-648.
Smith, et al., Pharmacology, 34:69-16, 1986.
Feuer, et al., Xenobiotica, 1985, 15(5) 407-412.
Kitchin, Int. J. Biochemistry, 15(4) 479-85, 1981.
Gilbraith, et al., Pharmacology, 34, 241-19 (1987).
Davis, et al., J. Lab. Clin. Med. 95(5), 1980, pp. 714-724.
Chemical Abstracts, 61:8792 (J-P), 1964.
Chemical Abstracts, vol. 64, 1966, Abstract 7243h.
Belovetskaya, Chemical Abstracts, vol. 100, 1982, Abstract 45779k.
Smith, et al., Pharmacology, 349-16, 1986.
Smith, et al., Proc. Natl. Acad. Sci. USA, 79, 7537-41, 1982.
Drummond George S.
Kappas Attallah
Shah Mukund J.
The Rockefeller University
Ward E. C.
LandOfFree
Method of controlling T.sub.3 and T.sub.4 levels in vivo with co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of controlling T.sub.3 and T.sub.4 levels in vivo with co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of controlling T.sub.3 and T.sub.4 levels in vivo with co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-782023